6 Analysts Have This To Say About Corcept Therapeutics
6 Analysts Have This To Say About Corcept Therapeutics
6位分析师对corcept医疗发表看法
During the last three months, 6 analysts shared their evaluations of Corcept Therapeutics (NASDAQ:CORT), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，有6位分析师分享了他们对Corcept Therapeutics（纳斯达克：CORT）的评价，展现出看好和看淡各异的前景。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $48.67, a high estimate of $65.00, and a low estimate of $38.00. Surpassing the previous average price target of $45.80, the current average has increased by 6.27%.
12个月的分析师价格目标揭示了一些分析师的见解，呈现出平均目标价格为48.67美元，最高估价为65.00美元，最低估价为38.00美元。当前的平均目标价格已经超过了先前的平均目标价格45.80美元，增加了6.27%。
Diving into Analyst Ratings: An In-Depth Exploration
深入探讨分析师评级：分析师评级的深度探讨
The analysis of recent analyst actions sheds light on the...
最近分析师行动的分析...
登录免费看全文
登录/注册